Thinking of joining a study?

Register your interest

NCT05570357 | COMPLETED | Diabetes

Berberine and Cinnamon in Management of Diabetes

National Nutrition and Food Technology Institute

Information provided by (Responsible Party):

Dr Azita Hekmatdoost

Brief Summary:

In this randomized clinical trial, patients with diabetes will be randomly assigned to receive either Berberine, and Cinnamon supplements or placebo for 12 weeks. Then the glycemic characteristics will be compared in two groups.

Condition or disease



Berberine+Cinnamon (TDS)

Placebo (TDS)



Estimated Enrollment : 44 participants
Masking : TRIPLE
Primary Purpose : TREATMENT
Official Title : The Effects of Berberine and Cinnamon Supplementation on Diabetes Management
Actual Study Start Date : 2022-07-01
Estimated Primary Completion Date : 2023-01-01
Estimated Study Completion Date : 2023-02-10

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 20 Years to 65 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Inclusion Criteria
  • * Age 30-70 years
  • * Diagnosed type-2 diabetes mellitus (based on American Diabetes Association criteria)
Exclusion Criteria
  • * Patients with an allergy to berberine /cinamon
  • * Lactation, pregnancy
  • * Patients with any malignancy
  • * Patients with unrelated chronic illness
  • * Patients with cardiac, liver or respiratory failure

Berberine and Cinnamon in Management of Diabetes

Location Details


Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.


Not yet recruiting

Iran, Islamic Republic of, Middle East

Azita Hekmatdoost

Tehran, Middle East, Iran, Islamic Republic of, 19835